Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-auricular Topical Lidocaine for Tinnitus
NCT05711641Completed
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Sep 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of lidocaine 10% oropharyngeal spray in tinnitus (2 arms), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Primary endpoints: Visual Analogue Scale at Day 15, Tinnitus Loudness at Day 15 and 1 more. Started Sep 2022; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
tinnitus
Beyond the preview
Go deeper on NCT05711641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05711641.